These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27703023)

  • 1. Dosing and therapeutic drug monitoring of voriconazole in bottlenose dolphins (Tursiops truncatus).
    Ferrier K; van Elk CE; Bunskoek PE; van den Broek M
    Med Mycol; 2017 Feb; 55(2):155-163. PubMed ID: 27703023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voriconazole dosing and therapeutic drug monitoring in children: experience from a paediatric tertiary care centre.
    Boast A; Curtis N; Cranswick N; Gwee A
    J Antimicrob Chemother; 2016 Jul; 71(7):2031-6. PubMed ID: 27009030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First isolation of voriconazole-resistant Candida albicans, C. tropicalis, and Aspergillus niger from the blowholes of bottlenose dolphins (Tursiops truncatus).
    Ohno Y; Akune Y; Inoshima Y; Kano R
    J Vet Med Sci; 2019 Nov; 81(11):1628-1631. PubMed ID: 31611481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Optimized Voriconazole Dosing Strategy to Achieve Therapeutic Serum Concentrations in Children Younger than 2 Years Old.
    Zembles TN; Thompson NE; Havens PL; Kaufman BA; Huppler AR
    Pharmacotherapy; 2016 Oct; 36(10):1102-1108. PubMed ID: 27548272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placental and breastmilk transfer of voriconazole to offspring from pregnant and lactating bottlenose dolphins (Tursiops truncatus).
    Ohno Y; Kobayashi M; Akune Y; Inoshima Y
    Med Mycol; 2020 Jun; 58(4):469-477. PubMed ID: 31504741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose optimisation of voriconazole with therapeutic drug monitoring in children: a single-centre experience in China.
    Liu L; Zhou X; Wu T; Jiang H; Yang S; Zhang Y
    Int J Antimicrob Agents; 2017 Apr; 49(4):483-487. PubMed ID: 28159657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of Saliva as an Alternative to Plasma Monitoring of Voriconazole.
    Vanstraelen K; Maertens J; Augustijns P; Lagrou K; de Loor H; Mols R; Annaert P; Malfroot A; Spriet I
    Clin Pharmacokinet; 2015 Nov; 54(11):1151-60. PubMed ID: 25910879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin blood concentration and vitamin supplementation in bottlenose dolphins (Tursiops truncatus) in European facilities.
    Gimmel AE; Baumgartner K; Liesegang A
    BMC Vet Res; 2016 Sep; 12(1):180. PubMed ID: 27596136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PHARMACOKINETICS OF ORALLY ADMINISTERED VORICONAZOLE IN AFRICAN PENGUINS (SPHENISCUS DEMERSUS) AFTER SINGLE AND MULTIPLE DOSES.
    Hyatt MW; Wiederhold NP; Hope WW; Stott KE
    J Zoo Wildl Med; 2017 Jun; 48(2):352-362. PubMed ID: 28749255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of single dose oral meloxicam in bottlenose dolphins (Tursiops truncatus).
    Simeone CA; Nollens HH; Meegan JM; Schmitt TL; Jensen ED; Papich MG; Smith CR
    J Zoo Wildl Med; 2014 Sep; 45(3):594-9. PubMed ID: 25314827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding variability with voriconazole using a population pharmacokinetic approach: implications for optimal dosing.
    Dolton MJ; Mikus G; Weiss J; Ray JE; McLachlan AJ
    J Antimicrob Chemother; 2014 Jun; 69(6):1633-41. PubMed ID: 24554646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying factors affecting the pharmacokinetics of voriconazole in patients with liver dysfunction: A population pharmacokinetic approach.
    Tang D; Song BL; Yan M; Zou JJ; Zhang M; Zhou HY; Wang F; Xiao YW; Xu P; Zhang BK; Chen XJ; Xiang DX; Linh Banh H
    Basic Clin Pharmacol Toxicol; 2019 Jul; 125(1):34-43. PubMed ID: 30715804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetic model-guided optimization of intravenous voriconazole dosing regimens in critically ill patients with liver dysfunction.
    Lin XB; Lui KY; Guo PH; Liu XM; Liang T; Hu XG; Tong L; Wu JJ; Xia YZ; Chen P; Zhong GP; Chen X; Cai CJ
    Pharmacotherapy; 2022 Jan; 42(1):23-33. PubMed ID: 34655497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric Clinical Pharmacology of Voriconazole: Role of Pharmacokinetic/Pharmacodynamic Modeling in Pharmacotherapy.
    Kadam RS; Van Den Anker JN
    Clin Pharmacokinet; 2016 Sep; 55(9):1031-43. PubMed ID: 26979736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of dose adaptations following voriconazole therapeutic drug monitoring in pediatric patients.
    Lempers VJ; Meuwese E; Mavinkurve-Groothuis AM; Henriet S; van der Sluis IM; Hanff LM; Warris A; Koch BCP; Brüggemann RJ
    Med Mycol; 2019 Nov; 57(8):937-943. PubMed ID: 30759261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. POPULATION PHARMACOKINETICS OF CEFPODOXIME IN BOTTLENOSE DOLPHINS (
    Linnehan BK; Lesman SP; Boucher JF; Grover GS; Brodie EC; Meegan JM; McClain AM; Ross KP; Jensen ED
    J Zoo Wildl Med; 2024 Sep; 55(3):611-619. PubMed ID: 39255202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and distribution of voriconazole in body fluids of dogs after repeated oral dosing.
    Lemetayer JD; Dowling PM; Taylor SM; Papich MG
    J Vet Pharmacol Ther; 2015 Oct; 38(5):451-6. PubMed ID: 25691353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and testing of species-specific ELISA assays to measure IFN-γ and TNF-α in bottlenose dolphins (Tursiops truncatus).
    Eberle KC; Venn-Watson SK; Jensen ED; LaBresh J; Sullivan Y; Kakach L; Sacco RE
    PLoS One; 2018; 13(1):e0190786. PubMed ID: 29304133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of total and free voriconazole in human plasma: Application to pharmacokinetic study and therapeutic monitoring.
    Resztak M; Kosicka K; Zalewska P; Krawiec J; Główka FK
    J Pharm Biomed Anal; 2020 Jan; 178():112952. PubMed ID: 31708268
    [No Abstract]   [Full Text] [Related]  

  • 20. Using Child-Pugh Class to Optimize Voriconazole Dosage Regimens and Improve Safety in Patients with Liver Cirrhosis: Insights from a Population Pharmacokinetic Model-based Analysis.
    Wang T; Yan M; Tang D; Dong Y; Zhu L; Du Q; Sun D; Xing J; Dong Y
    Pharmacotherapy; 2021 Feb; 41(2):172-183. PubMed ID: 33064889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.